🇺🇸 Intralesional Steroid Injection in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 3
Most-reported reactions
- Headache — 1 report (33.33%)
- Product Contamination Microbial — 1 report (33.33%)
- Urticaria — 1 report (33.33%)
Other Dermatology approved in United States
Frequently asked questions
Is Intralesional Steroid Injection approved in United States?
Intralesional Steroid Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Intralesional Steroid Injection in United States?
Services Institute of Medical Sciences, Pakistan is the originator. The local marketing authorisation holder may differ — check the official source linked above.